@entity170 is a @entity262 characterized by low bone mass and @entity174 ( @entity3814 ) that may occur as a consequence. @entity3814 ( @entity3814 ) can lead to severe acute and chronic @entity158 , @entity73 , reduced quality of life and an increased risk of mortality due to decreased mobility and @entity358 . When @entity158 @entity3814 do come to clinical attention, they are typically treated with @entity158 management (OPM). Although the natural course of @entity158 due to vertebral fractures decreases within the first weeks in the majority of @entity1 , a number of them remain with persistent @entity158 and/or ongoing @entity891 . Facet joint injections are an emerging procedure as possible treatment for a subgroup of @entity1 with persistent @entity158 after @entity3814 . In case of @entity891 or persistent @entity158 after facet joint injections, @entity1 have to be treated with percutaneous vertebroplasty ( @entity12468 ) or percutaneous balloon kyphoplasty (BKP). @entity12468 is a minimally invasive surgical procedure in which bone cement is injected into a fractured @entity5788 under radiological guidance using fluoroscopy. BKP is a variation of this approach, in which an inflatable balloon tamp is placed in the collapsed @entity5788 prior to cement injection, in order to create a cavity allowing low pressure injection. For peo- ple with @entity158 @entity3814 refractory to analgesic treatment, @entity12468 and BKP perform significantly better in unblinded trials than OPM in terms of improving quality of life and reducing @entity158 and disability. It is possible that BKP and @entity12468 may lead to reductions in mortality. In small subgroup of @entity1 with @entity16 related to an @entity3604 , different open surgical techniques were used to suit different fracture patterns, with good clinical and radiological results.

[Diagnostics and treatment of XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity5788 :: ('MESH:C562952', 'Disease') :: ['vertebra'] @entity3604 :: ('MESH:D058866', 'Disease') :: ['osteoporotic fracture'] @entity174 :: ('MESH:D050723', 'Disease') :: ['microarchitectural deterioration of bone tissue, with vertebral compressive fractures'] @entity73 :: ('MESH:D003072', 'Disease') :: ['impaired mobility'] @entity16 :: ('MESH:D009422', 'Disease') :: ['neurological injury'] @entity170 :: ('MESH:D010024', 'Disease') :: ['Osteoporosis'] @entity262 :: ('MESH:D034721', 'Disease') :: ['systemic skeletal disease'] @entity3814 :: ('MESH:D050815', 'Disease') :: ['VCFs', 'osteoporotic VCFs', 'Vertebral compression fractures'] @entity12468 :: ('CHEBI:53245', 'Chemical') :: ['PVP'] @entity891 :: ('MESH:D001261', 'Disease') :: ['vertebral collapse'] @entity358 :: ('MESH:D008171', 'Disease') :: ['pulmonary dysfunction'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain', 'painful', 'optimal pain']
@entity3604 :: (MESH:D058866,Disease) :: ['osteoporotic vertebral fractures']
